BIM 189 acts as bombesin antagonist that reduces bombesin-induced satiety.
CAT# | R0869 |
CAS | 142062-55-3 |
Synonyms/Alias | [D-Phe6,Leu13,Cpa14]bombesin-(6-14)NH2 |
M.F/Formula | C56H73ClN14O10 |
M.W/Mr. | 1137.73 |
Sequence | H-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-Phe(4-Cl)-NH2 |
Labeling Target | Vombesin |
Appearance | White lyophilised solid |
Purity | >96% |
Activity | Antagonist |
Storage | -20°C | Long-term Storage Conditions | -20°C | InChI | InChI=1S/C56H73ClN14O10/c1-30(2)21-43(54(79)68-42(49(60)74)23-34-15-17-36(57)18-16-34)69-55(80)45(25-37-27-61-29-64-37)66-47(73)28-63-56(81)48(31(3)4)71-50(75)32(5)65-53(78)44(24-35-26-62-40-14-10-9-13-38(35)40)70-52(77)41(19-20-46(59)72)67-51(76)39(58)22-33-11-7-6-8-12-33/h6-18,26-27,29-32,39,41-45,48,62H,19-25,28,58H2,1-5H3,(H2,59,72)(H2,60,74)(H,61,64)(H,63,81)(H,65,78)(H,66,73)(H,67,76)(H,68,79)(H,69,80)(H,70,77)(H,71,75)/t32-,39+,41-,42-,43-,44-,45-,48-/m0/s1 | InChI Key | XJWMPWLZAVKSPK-UYBYNCNQSA-N | Isomeric SMILES | C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)Cl)C(=O)N)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](CC5=CC=CC=C5)N | BoilingPoint | 1600.4ºC at 760mmHg | Melting Point | N/A |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
R1900 | Murepavadin | Inquiry | ||
R1439 | IFN-α Receptor Recognition Peptide 1 | Inquiry | ||
R1263 | Calcitonin salmon | Inquiry | ||
R1564 | Nociceptin | Inquiry | ||
R1652 | Rat CGRP-(8-37) | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Brief information of orexin peptide The past several years have provided important insights into the physiological significan ...
KAI-1455, a ε-protein kinase C activator in Phase I testing for the treatment of ischemia-induced reperfusion i ...
The endocytosis of AMPA receptors (AMPARs) requires the GTPase activity of dynamin. Since it is now established ...
Octreotide, a long-acting structural derivative of somatostatins, is a synthetic peptide analog of somatostatin with the same ...
ClC-2 chloride channels are voltage-gated ion channels that are expressed in neuronal and epithelial cells wher ...